CNS Metastases Completed Phase 2 Trials for Temozolomide (DB00853)

Also known as: Metastases, CNS / Metastases to central nervous system / Central Nervous System (CNS) Metastases / Central Nervous System Metastases / Metastases of Central Nervous System / Metastatic malignant neoplasm to central nervous system (disorder) / CNS metastases (tumor staging)

IndicationStatusPhase
DBCOND0050898 (CNS Metastases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00831545Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)Treatment